Differential use of available genetic tests among primary care physicians in the United States: results of a national survey

被引:108
作者
Shields, Alexandra E. [1 ,2 ,3 ]
Burke, Wylie [4 ]
Levy, Douglas E. [1 ,2 ,3 ]
机构
[1] Massachusetts Gen Hosp, Ctr Genom Vulnerable Populat & Hlth Disparities, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Inst Hlth Policy, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
[4] Univ Washington, Dept Med Hist & Eth, Seattle, WA 98195 USA
关键词
physicians; genomics; genetic screening; clinical integration; new technologies;
D O I
10.1097/GIM.0b013e3181770184
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose: This study assesses primary care physicians' experience ordering and referring patients for genetic testing, and whether minority-serving physicians are less likely than those serving fewer minorities to offer such services. Methods: Survey of a random sample of 2000 primary care physicians in the United States (n = 1120, 62.3% response rate based on eligible respondents) conducted in 2002 to assess what proportion have (1) ever ordered a genetic test in general or for select conditions; (2) ever referred a patient for genetic testing to a genetics center or counselor, a specialist, a clinical research trial, or to any site of care. Results: Nationally, 60% of primary care physicians have ordered a genetic test and 74% have referred a patient for genetic testing. Approximately 62% of physicians have referred a patient for genetic testing to a genetics center/counselor or to a specialist, and 17% to a clinical trial. Minority-serving physicians were significantly less likely to have ever ordered a genetic test for breast cancer, colorectal cancer, or Huntington disease, or to have ever referred a patient for genetic testing relative to those serving fewer minorities. Conclusions: Reduced utilization of genetic tests/referrals among minority-serving physicians emphasizes the importance of tracking the diffusion of genomic medicine and assessing the potential impact on health disparities.
引用
收藏
页码:404 / 414
页数:11
相关论文
共 49 条
  • [1] *AM COLL OBST GYN, 2000, GEN SCREEN HEM ACOG
  • [2] *AM COLL OBST GYN, 2004, 298 ACOG COMM
  • [3] *AM MED ASS, 2002, AMA MAST
  • [4] [Anonymous], 1996, GUID CLIN PREV SERV
  • [5] Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer
    Armstrong, K
    Micco, E
    Carney, A
    Stopfer, J
    Putt, M
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (14): : 1729 - 1736
  • [6] Primary care physicians who treat blacks and whites
    Bach, PB
    Pham, HH
    Schrag, D
    Tate, RC
    Hargraves, JL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (06) : 575 - 584
  • [7] Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility:: Recommendation statement
    Berg, AO
    Allan, JD
    Calonge, N
    Frame, PS
    Gordis, L
    Gregory, KD
    Harris, R
    Johnson, MS
    Klein, JD
    Loveland-Cherry, C
    Moyer, VA
    Ockene, JK
    Petitti, DB
    Siu, AL
    Teutsch, SM
    Yawn, BP
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 143 (05) : 355 - 361
  • [8] Blumenthal D, 1999, J FAM PRACTICE, V48, P264
  • [9] Blumenthal D, 2006, HLTH INFORM TECHNOLO
  • [10] VARIATIONS IN THE USE OF MEDICATION FOR THE TREATMENT OF CHILDHOOD ASTHMA IN THE MICHIGAN MEDICAID POPULATION, 1980 TO 1986
    BOSCO, LA
    GERSTMAN, BB
    TOMITA, DK
    [J]. CHEST, 1993, 104 (06) : 1727 - 1733